The levels of lncRNA SARCC were increased in sunitinib-treated ccRCC cells, and high expression of SARCC enhanced the sensitivity of ccRCC cells to sunitinib [182]. Here, P2RY1 is linked to nonpapillary renal cell carcinoma.